Aortic Stiffness Can be Predicted From Different eGFR Formulas With Long Follow-Up in the Malmö Diet Cancer Study.
Anders ChristenssonSimon LundgrenMadeleine JohanssonPeter M NilsssonGunnar EngströmAgne Laucyte-CibulskienePublished in: Angiology (2024)
We studied the impact of estimated glomerular filtration rate (eGFR) based on either creatinine or cystatin C, or in combination, on vascular aging (aortic stiffness) and central hemodynamics (central systolic blood pressure) in a Swedish urban population with median 17 years of follow-up. Participants ( n = 5049) from the population-based Malmö Diet and Cancer Study that underwent baseline examination and later participated in the prospective cardiovascular arm were selected. Of these, 2064 with measured carotid-femoral pulse wave velocity (cfPWV) and central blood pressure at follow-up were enrolled. eGFR was calculated using cystatin C (eGFR CYS ) and creatinine (eGFR CR ) equations: Caucasian, Asian, pediatric, and adult cohorts (CAPA), the Lund-Malmö revised (LMrev), and the European Kidney Function Consortium (EKFC) equations. Lower adjusted eGFR CR , but not eGFR CYS , were independently associated with higher cfPWV ( P < .001, respectively). eGFR <60 mL/min/1.73 m 2 determined higher cfPWV except when using the EKFC equation. Conversely, CAPA/LMrev and CAPA/EKFC ratios were not associated with aortic stiffness. Lower eGFR CR is associated with higher future aortic stiffness independently of age, sex, heart rate, mean blood pressure, body mass index, and antihypertensive treatment. The ratio of eGFR CYS and eGFR CR equations could not predict aortic stiffness at all.
Keyphrases
- small cell lung cancer
- blood pressure
- epidermal growth factor receptor
- tyrosine kinase
- heart rate
- left ventricular
- aortic valve
- hypertensive patients
- heart failure
- pulmonary artery
- weight loss
- heart rate variability
- young adults
- type diabetes
- insulin resistance
- pulmonary arterial hypertension
- atrial fibrillation
- skeletal muscle
- smoking cessation
- blood glucose
- combination therapy
- glycemic control